Low density lipoprotein epidemiology and demographics: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
Overall, the prevalence of high LDL–C significantly decreased from 59% in 1976–1980 to 42% in 1988–1994, and to 33% in 2001–2004, reaching 27% in 2007–2010. | Overall, the prevalence of high LDL–C significantly decreased from 59% in 1976–1980 to 42% in 1988–1994, and to 33% in 2001–2004, reaching 27% in 2007–2010. | ||
The decrease in the prevalence of high LDL is paralleled by an increase in the use of cholesterol-lowering medication that grew from 5% in 1988–1994 to 17% in 2001–2004, and reached 23% in 2007–2010. In addition, the percentage of adults meeting guidelines for low saturated-fat intake increased significantly from 1976–1980 to 1988–1994, from 25% to 41%, but no significant change occurred from 1988–1994 through 2007–2010. | |||
Shown below is a diagram depicting the age-adjusted prevalence of high LDL cholesterol among adults aged 40–74, by sex and age in the United States between 1976–1980 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.) | Shown below is a diagram depicting the age-adjusted prevalence of high LDL cholesterol among adults aged 40–74, by sex and age in the United States between 1976–1980 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.) | ||
| Line 14: | Line 16: | ||
Shown below is a diagram depicting the age adjusted use of cholesterol-lowering medications among adults aged 40–74 in the United States between 1988–1994 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.) | Shown below is a diagram depicting the age adjusted use of cholesterol-lowering medications among adults aged 40–74 in the United States between 1988–1994 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.) | ||
[[File:Use of LDL lowering drugs.gif|Age adjusted use of cholesterol-lowering medications among adults aged 40–74 in the United States between 1988–1994 and 2007–2010]] | |||
===Gender=== | ===Gender=== | ||
Revision as of 13:43, 27 September 2014
Template:Low density lipoprotein Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Epidemiology and Demographics
Prevalence
Overall, the prevalence of high LDL–C significantly decreased from 59% in 1976–1980 to 42% in 1988–1994, and to 33% in 2001–2004, reaching 27% in 2007–2010.
The decrease in the prevalence of high LDL is paralleled by an increase in the use of cholesterol-lowering medication that grew from 5% in 1988–1994 to 17% in 2001–2004, and reached 23% in 2007–2010. In addition, the percentage of adults meeting guidelines for low saturated-fat intake increased significantly from 1976–1980 to 1988–1994, from 25% to 41%, but no significant change occurred from 1988–1994 through 2007–2010.
Shown below is a diagram depicting the age-adjusted prevalence of high LDL cholesterol among adults aged 40–74, by sex and age in the United States between 1976–1980 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.)
Shown below is a diagram depicting the age adjusted use of cholesterol-lowering medications among adults aged 40–74 in the United States between 1988–1994 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.)
Gender
Between 1976–1980 and 2007–2010, the prevalence of high LDL–C significantly decreased for men from 65% to 31%.
The prevalence of high LDL–C also significantly decreased for and women from 54% to 24% between 1976–1980 and 2007–2010.
Age
Between 1976–1980 and 2007–2010, the prevalence of high LDL–C significantly decreased for adults aged 40–64 (56% to 27%) and 65–74 (72% to 30%).